Alerts will be sent to your verified email
Verify Email
PAR
|
Par Drugs & Chem.
|
Resonance Specialtie
|
Evexia Lifecare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.79 % | 14.83 % | 1.81 % |
|
5yr average Equity Multiplier
|
1.28 | 1.22 | 4.48 |
|
5yr Average Asset Turnover Ratio
|
0.92 | 1.06 | 0.39 |
|
5yr Avg Net Profit Margin
|
14.32 % | 10.72 % | 1.86 % |
|
Price to Book
|
0.99 | 1.5 | 0.17 |
|
P/E
|
7.58 | 11.23 | 59.62 |
|
5yr Avg Cash Conversion Cycle
|
-12.24 Days | 111.92 Days | 34.71 Days |
|
Inventory Days
|
16.4 Days | 98.79 Days | 7.89 Days |
|
Days Receivable
|
48.97 Days | 83.71 Days | 242.85 Days |
|
Days Payable
|
90.62 Days | 91.05 Days | 189.05 Days |
|
5yr Average Interest Coverage Ratio
|
113.93 | 78.86 | 43.66 |
|
5yr Avg ROCE
|
20.52 % | 19.79 % | 1.65 % |
|
5yr Avg Operating Profit Margin
|
22.04 % | 15.26 % | -13.3 % |
|
5 yr average Debt to Equity
|
0.03 | 0.04 | 2.67 |
|
5yr CAGR Net Profit
|
2.85 % | -8.99 % | -18.73 % |
|
5yr Average Return on Assets
|
13.02 % | 12.27 % | 0.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.41 % | 54.25 % | 3.49 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.8 % | 0.0 | -7.1 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.06 % |
|
Par Drugs & Chem.
|
Resonance Specialtie
|
Evexia Lifecare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Raw Material Breakup
|
Raw Material Breakup
|
-
|
-
|